SB
Vice President, NALA Regulatory Affairs, BeiGene, United States
JL
NALA Regulatory Affairs Policy Head, BeiGene, Inc., United States
Lindsay is currently the Regulatory Policy Head, NALA Regulatory Policy & Intelligence at BeiGene. BeiGene, founded in 2010, is a biotechnology company that specializes in the development of cancer treatments. As the NALA Policy Head, Lindsay leads a team responsible for analyzing...
Read More → LF
Associate Director, Science and Policy to Address Disparities, OCE, FDA, United States
Lola Fashoyin-Aje is a medical oncologist and Deputy Director in the Division of Oncology 3 in the Office of Oncologic Diseases at CDER/FDA. She provides scientific and policy guidance and oversight for the review of drugs under development for the treatment of solid tumor malignancies...
Read More → TJ
Deputy Director and Chief Operating Officer YCCI; Director for Clinical Research, Yale University School of Medicine, United States
Chief Executive Officer, Reagan-Udall Foundation, United States
Prior to accepting the post at the FDA’s Foundation in May of 2020, she served as President of Leavitt Partners Solutions. She advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders...
Read More →
Chief Executive Officer, Reagan-Udall Foundation, United States
Prior to accepting the post at the FDA’s Foundation in May of 2020, she served as President of Leavitt Partners Solutions. She advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders...
Read More →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
